Northeast Pharmaceutical Group Co Ltd (000597)

Currency in CNY
5.77
0.00(0.00%)
Closed·
000597 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
000597 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5.705.81
52 wk Range
3.996.69
Key Statistics
Bid/Ask
5.77 / 5.77
Prev. Close
5.77
Open
5.78
Day's Range
5.7-5.81
52 wk Range
3.99-6.69
Volume
23.25M
Average Volume (3m)
26.19M
1-Year Change
7.85%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
000597 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Northeast Pharmaceutical Group Co Ltd Company Profile

Northeast Pharmaceutical Group Co., Ltd. engages in chemical pharmaceuticals preparations, pharmaceutical business, pharmaceutical engineering, biomedicine, and other businesses in China. It offers vitamin products, including vitamin C, vitamin B1, vitamin B6, and levocarnitine series; anti-infection products, such as fosfomycin series, azithromycin series, berberine hydrochloride, chloramphenicol, and other products; and reproductive system and sex hormone products comprising carboprost suppositories, carboprost tromethamine, dapoxetine hydrochloride, and levonorgestrel and tadalafil tablets. The company also provides nervous system products, such as piracetam series, levetiracetam series, vinpocetine, and other products; narcotics and narcotic-containing products, including morphine hydrochloride injection, pethidine hydrochloride injection, morphine hydrochloride tablets, oxycodone hydrochloride injection, and other products; anti-AIDS products comprising kedu/zidovudine tablets, kedu/zidovudine capsules, efavirenz tablets, zidolamid bivudine tablets, and other products; and in vitro biological diagnostic reagent products, such as HIV, HBV, HCV, HPV, and TB molecular diagnostic reagents. In addition, it offers general health products, including vitamin C powder, effervescent tablets, chewable tablets, solid drinks, glycosaminoglycan chondroitin sulfate collagen D3 calcium capsules, protein powder, probiotic powder, and other products. Further, the company provides Zhengchangsheng aluminum carbonate magnesium chewable tablets; Zhenxiwei compound proglumide and cimetidine tablets; amlodipine maleate; compound licorice series; narcotine syrup; Kefei, a compound codeine phosphate syrup; Xiaoke, a citronix tablets; acetaminophen tablets, pain-relieving tablets; metronidazole tablets; tinidazole tablets; paracetamol tablets; and other products. Additionally, it engages in medical distribution business. The company was founded in 1946 and is based in Shenyang, China.

Employees
5964
Market
China

Compare 000597 to Peers and Sector

Metrics to compare
000597
Peers
Sector
Relationship
P/E Ratio
21.2x30.5x−0.5x
PEG Ratio
1.53−0.170.00
Price/Book
1.5x3.2x2.6x
Price / LTM Sales
1.1x4.8x3.3x
Upside (Analyst Target)
-15.0%43.5%
Fair Value Upside
Unlock4.8%6.8%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.27%
Dividend Yield
1.73%
Industry Median 1.51%
Annualised payout
0.10
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 28, 2025
EPS / Forecast
0.03 / --
Revenue / Forecast
1.95B / --
EPS Revisions
Last 90 days

000597 Income Statement

FAQ

What Stock Exchange Does Northeast Phar A Trade On?

Northeast Phar A is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for Northeast Phar A?

The stock symbol for Northeast Phar A is "000597."

What Is the Northeast Phar A Market Cap?

As of today, Northeast Phar A market cap is 8.23B.

What Is Northeast Phar A's Earnings Per Share (TTM)?

The Northeast Phar A EPS (TTM) is 0.27.

From a Technical Analysis Perspective, Is 000597 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Northeast Phar A Stock Split?

Northeast Phar A has split 5 times.

How Many Employees Does Northeast Phar A Have?

Northeast Phar A has 5964 employees.

What is the current trading status of Northeast Phar A (000597)?

As of 09 Aug 2025, Northeast Phar A (000597) is trading at a price of 5.77, with a previous close of 5.77. The stock has fluctuated within a day range of 5.70 to 5.81, while its 52-week range spans from 3.99 to 6.69.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.